US News

CDC panel considers recommending mRNA COVID-19 vaccines over J&J’s

Published by

By Michael Erman (Reuters) – A panel of outside advisers to the U.S. Centers for Disease Control and Prevention was considering on Thursday whether to recommend that Americans choose to receive one of the two authorized messenger RNA (mRNA) COVID-19 vaccines over Johnson & Johnson’s shot, due to rare but sometimes fatal cases of blood clotting. J&J’s vaccine uses a technology based on a modified version of an adenovirus to spur immunity in recipients, while the Moderna and Pfizer/BioNTech vaccines use mRNA technology. The CDC’s Advisory Committee on Immunization practices was expected to vote …

Read More

Facebook Comments

Check Also

Forget working from home — why not live in an old office?

Published by AFP Washington (AFP) – Blocks from ...